Biotech · Private company · San Diego, CA, US
Catrx, Inc.
Track this companyFree. Adds Catrx, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards1
- JAML is a first-in-class cancer immunotherapy target for tissue-resident memory T cells.Fiscal year 2026 · $400KNIH RePORTER 1R44CA306698-01A1 · fetched Nov 12, 2026